Table 1 Selection criteria for subjects and the included subject numbers in this case-control study
From: Reevaluating Adiponectin’s impact on obesity hypertension: a Chinese case-control study
Group | Inclusion Criteria | Exclusion Criteria |
|---|---|---|
NH | • People without a clinically serious ailment, such as obesity, hypertension, or another condition | • Not meet the Inclusion Criteria as the left • Refuse to give informed consent |
JO | • Participants having not been given an anti-obesity medication prescription or received an obesity diagnosis prior to this yearly physical examination | • Being diagnosed as secondary hypertension, heart, kidney, liver, or other endocrine diseases, severe chronic diabetic complications, any recent acute illness, refusal to give informed consent |
JH | • Individuals having not had their hypertension identified or treated with any anti-hypertension medications prior to this annual physical check | |
OH | • Subjects having not been given a diagnosis of obesity or hypertension and not received any treatment for those conditions until this annual physical examination |